<DOC>
	<DOCNO>NCT00914693</DOCNO>
	<brief_summary>The aim present study prove efficacy safety new contraceptive patch .</brief_summary>
	<brief_title>EU/LA Pearl Index Study - Transdermal Contraceptive Patch</brief_title>
	<detailed_description />
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Gestodene</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Femovan</mesh_term>
	<criteria>Requiring contraception Normal cervical smear Smokers old 30 year History regular cyclic menstrual period Pregnancy lactation Obesity ( BMI &gt; 30 kg/m2 Significant skin reaction transdermal preparation sensitivity surgical / medical tape Any disease may worsen hormonal treatment ( cardiovascular , liver , metabolic ) Use contraceptive method study medication</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Fertility control</keyword>
	<keyword>Contraception</keyword>
</DOC>